We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Ethambutol Impurity 1
N-Nitroso Ethambutol Impurity 1
CAT No SRC-N0142873
CAS No NA
Mol.F. C10H19N3O5
Mol.Wt. 261.28 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Amino Ethyl Desmethoxy Fluoxamine
N-Nitroso Amino Ethyl Desmethoxy Fluoxamine
CAT No SRC-N0142874
CAS No NA
Mol.F. C17H25F3N4O2
Mol.Wt. 374.4 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Fluvoxamine Impurity 2
N-Nitroso Fluvoxamine Impurity 2
CAT No SRC-N0142875
CAS No NA
Mol.F. C17H24F3N3O2
Mol.Wt. 359.39g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Fluvoxamine Maleic Acid Monoamide Impurity
N-Nitroso Fluvoxamine Maleic Acid Monoamide Impurity
CAT No SRC-N0142876
CAS No NA
Mol.F. C19H22F3N3O6
Mol.Wt. 445.40 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso N-Boc Fluvoxamine
N-Nitroso N-Boc Fluvoxamine
CAT No SRC-N0142877
CAS No NA
Mol.F. C20H28F3N3O5
Mol.Wt. 447.46 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Fluvoxamine Acid N-Acetyl Impurity
N-Nitroso Fluvoxamine Acid N-Acetyl Impurity
CAT No SRC-N0142878
CAS No NA
Mol.F. C16H18F3N3O5
Mol.Wt. 389.33 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Fluvoxamine Impurity 3
N-Nitroso Fluvoxamine Impurity 3
CAT No SRC-N0142879
CAS No NA
Mol.F. C16H23F3N4O3
Mol.Wt. 376.38 g/mol
INV STATUS UNDER SYNTHESIS
N-Nitroso Fluvoxamine Impurity 6
N-Nitroso Fluvoxamine Impurity 6
CAT No SRC-N0142880
CAS No NA
Mol.F. C15H22F3N3O4
Mol.Wt. 365.35g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Fluvoxamine Impurity 9
N-Nitroso Fluvoxamine Impurity 9
CAT No SRC-N0142881
CAS No NA
Mol.F. C19H22F3N3O6
Mol.Wt. 445.40 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Fenoterol EP Impurity A
N-Nitroso Fenoterol EP Impurity A
CAT No SRC-N0142882
CAS No NA
Mol.F. C17H20N2O5
Mol.Wt. 332.36 g/mol
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.